| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 963 | 2.732 | 3.651 | 4.186 | 5.990 | 17.920 | 19.730 | 24.337 |
| Total Income - EUR | - | - | 963 | 2.732 | 3.651 | 4.186 | 5.990 | 17.920 | 19.730 | 24.337 |
| Total Expenses - EUR | - | - | 0 | 129 | 0 | 0 | 121 | 31 | 7.818 | 11.235 |
| Gross Profit/Loss - EUR | - | - | 963 | 2.603 | 3.651 | 4.186 | 5.868 | 17.889 | 11.912 | 13.102 |
| Net Profit/Loss - EUR | - | - | 934 | 2.521 | 3.541 | 4.060 | 5.692 | 17.472 | 11.719 | 12.409 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Guţă Uromedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 131 | 0 | 0 | 0 | -121 | -122 | -121 | 0 |
| Current Assets | - | - | 997 | 3.501 | 6.997 | 10.801 | 16.293 | 23.067 | 40.189 | 7.892 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 686 | 421 | 413 | 32 | 406 | 2.549 | 2.766 |
| Cash | - | - | 997 | 2.815 | 6.575 | 10.387 | 16.261 | 22.661 | 37.640 | 5.126 |
| Shareholders Funds | - | - | 978 | 2.564 | 3.583 | 4.101 | 5.733 | 17.513 | 29.179 | 4.026 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 150 | 936 | 3.413 | 6.700 | 10.438 | 5.433 | 10.889 | 3.866 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Guţă Uromedical Srl